Chronic myelogenous leukemia: mechanisms underlying disease progression
- 31 July 2002
- journal article
- review article
- Published by Springer Nature in Leukemia
- Vol. 16 (8) , 1402-1411
- https://doi.org/10.1038/sj.leu.2402577
Abstract
Leukemia is one of the leading journals in hematology and oncology. It is published monthly and covers all aspects of the research and treatment of leukemia and allied diseases. Studies of normal hemopoiesis are covered because of their comparative relevance.Keywords
This publication has 157 references indexed in Scilit:
- Blockade of the Bcr-Abl Kinase Activity Induces Apoptosis of Chronic Myelogenous Leukemia Cells by Suppressing Signal Transducer and Activator of Transcription 5–Dependent Expression of Bcl-XLThe Journal of Experimental Medicine, 2000
- The P190, P210, and P230 Forms of the BCR/ABL Oncogene Induce a Similar Chronic Myeloid Leukemia–like Syndrome in Mice but Have Different Lymphoid Leukemogenic ActivityThe Journal of Experimental Medicine, 1999
- Bcr phosphorylated on tyrosine 177 binds Grb2Oncogene, 1997
- Tyrosine phosphorylation of p120cbl in BCR/abl transformed hematopoietic cells mediates enhanced association with phosphatidylinositol 3-kinaseOncogene, 1997
- Regulation of Bcl-2 gene expression by BCR-ABL is mediated by RasJournal of Molecular Biology, 1997
- Role of p53 in leukemogenesis of chronic myeloid leukemiaThe International Journal of Cell Cloning, 1995
- Differential Complementation of Bcr-Abl Point Mutants with c-MycScience, 1994
- Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogeneCell, 1991
- Studies of proto-oncogene expression in the chronic and blastic phases of chronic myelogenous leukemiaEuropean Journal of Cancer and Clinical Oncology, 1990
- A splicing mutation accounts for the lack of p53 gene expression in a CML blast crisis cell line: a novel mechanism of p53 gene inactivationBritish Journal of Haematology, 1990